NasdaqGS:EXELBiotechs
Assessing Exelixis (EXEL) Valuation After Recent Short Term Share Price Weakness
Exelixis (EXEL) has been on investors’ radar after recent share price moves, with the stock showing a mix of short term weakness and longer term gains that invites a closer look at its fundamentals.
See our latest analysis for Exelixis.
The recent 1 day and 7 day share price declines sit against a longer stretch of positive momentum, with a 90 day share price return of 7.5% and a 1 year total shareholder return of 14.3%. This indicates that sentiment has generally improved over time despite...